CY1110605T1 - Διαδικασια για την παρασκευη ενωσεων πυριμιδινης - Google Patents

Διαδικασια για την παρασκευη ενωσεων πυριμιδινης

Info

Publication number
CY1110605T1
CY1110605T1 CY20101100025T CY101100025T CY1110605T1 CY 1110605 T1 CY1110605 T1 CY 1110605T1 CY 20101100025 T CY20101100025 T CY 20101100025T CY 101100025 T CY101100025 T CY 101100025T CY 1110605 T1 CY1110605 T1 CY 1110605T1
Authority
CY
Cyprus
Prior art keywords
compound
formula
preparation
alkyl
group
Prior art date
Application number
CY20101100025T
Other languages
English (en)
Inventor
Lee Newton
Mark Bailey
Original Assignee
Astrazeneca Uk Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0229243A external-priority patent/GB0229243D0/en
Priority claimed from GB0303589A external-priority patent/GB0303589D0/en
Priority claimed from GB0318515A external-priority patent/GB0318515D0/en
Application filed by Astrazeneca Uk Limited filed Critical Astrazeneca Uk Limited
Publication of CY1110605T1 publication Critical patent/CY1110605T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/716Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Παρέχονται μία διαδικασία για την παρασκευή μίας ένωσης του Τύπου (I) και ενδιαμέσων χρήσιμων σ' αυτήν. Η διαδικασία περιλαμβάνει την αντίδραση μίας ένωσης του τύπου R1-CO-CH2-E με μία ένωση του τύπου R2-CHX1X2 υπό την παρουσία μίας ένωσης του τύπου R3R4N-C(=NH)NH2 και ενός καταλύτη, για να σχηματιστεί έτσι μία διυδροπυριμιδίνη· και την οξείδωση της διυδροπυριμιδίνης για να σχηματιστεί μία ένωση του Τύπου (1). To R1 είναι Η ή μία αλκυλ ομάδα· το R2 είναι Η, μία αλκυλ ή αρυλ ομάδα· τα R3 και R4 είναι, το καθένα ανεξάρτητα, Η, αλκυλ ή αρυλ, ή τα R3 και R4 ενώνονται για να σχηματιστεί, μαζί με το άζωτο στο οποίο είναι αυτά προσαρτημένα, για να σχηματιστεί ένας 5 έως 7μελής ετεροκυκλικός δακτύλιος· το Ε είναι Η, μία μη υποκατεστημένη αλκυλ ομάδα, μία αρυλ ομάδα ή μία ομάδα απόσυρσης ηλεκτρονίων· και τα Χ1 και Χ2 είναι το καθένα ανεξάρτητα ομάδες αναχώρησης, ή τα Χ1 και Χ2 αντιπροσωπεύουν μαζί =O.
CY20101100025T 2002-12-16 2010-01-11 Διαδικασια για την παρασκευη ενωσεων πυριμιδινης CY1110605T1 (el)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0229243A GB0229243D0 (en) 2002-12-16 2002-12-16 Compounds and process
GB0303589A GB0303589D0 (en) 2003-02-17 2003-02-17 Compounds and process
GB0318515A GB0318515D0 (en) 2003-08-07 2003-08-07 Compounds and process
EP03780362A EP1578731B1 (en) 2002-12-16 2003-12-09 Process for the preparation of pyrimidine compounds

Publications (1)

Publication Number Publication Date
CY1110605T1 true CY1110605T1 (el) 2015-04-29

Family

ID=32600665

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100025T CY1110605T1 (el) 2002-12-16 2010-01-11 Διαδικασια για την παρασκευη ενωσεων πυριμιδινης

Country Status (23)

Country Link
US (2) US7524955B2 (el)
EP (2) EP1578731B1 (el)
JP (2) JP4579821B2 (el)
KR (1) KR101060215B1 (el)
AR (1) AR042355A1 (el)
AT (1) ATE448209T1 (el)
AU (1) AU2003288443B2 (el)
BR (1) BR0317313A (el)
CA (1) CA2509344C (el)
CY (1) CY1110605T1 (el)
DE (1) DE60330050D1 (el)
DK (1) DK1578731T3 (el)
ES (1) ES2335279T3 (el)
HK (1) HK1080477A1 (el)
IL (1) IL168884A (el)
MX (1) MXPA05006425A (el)
MY (1) MY138051A (el)
NO (2) NO330983B1 (el)
NZ (1) NZ540722A (el)
PT (1) PT1578731E (el)
SI (1) SI1578731T1 (el)
TW (1) TWI322145B (el)
WO (1) WO2004054986A2 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011120D0 (en) 2000-05-09 2000-06-28 Avecia Ltd Process
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
AU2002318041B2 (en) 2001-07-13 2008-01-03 Astrazeneca Uk Limited Preparation of aminopyrimidine compounds
EP1323717A1 (en) 2001-12-27 2003-07-02 Dsm N.V. Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
KR20030092446A (ko) * 2002-05-29 2003-12-06 주식회사 한국토종약초연구소 씨형 간염 활성 억제를 갖는 조릿대 추출물을 포함하는조성물
EP1375493A1 (en) 2002-06-17 2004-01-02 Dsm N.V. Process for the preparation of an dioxane acetic acid ester
GB0218781D0 (en) * 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
EP1578731B1 (en) 2002-12-16 2009-11-11 AstraZeneca UK Limited Process for the preparation of pyrimidine compounds
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
UY28501A1 (es) * 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0324791D0 (en) * 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
US8153791B2 (en) 2005-12-21 2012-04-10 Janssen Pharmaceutica N.V. Substituted pyrimidinyl oxime kinase inhibitors
WO2007109783A2 (en) * 2006-03-23 2007-09-27 Janssen Pharmaceutica, N.V. Substituted pyrimidine kinase inhibitors
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process
AU2011255457A1 (en) 2010-05-21 2012-12-06 Cooper Technologies Company Adapter for bushing latch

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278001A (en) * 1965-02-02 1966-10-11 Charles C Andrews Bearing assembly for auger conveyors
US4698340A (en) 1984-07-19 1987-10-06 Fujisawa Pharmaceutical Co., Ltd. Pyrimidine derivatives, processes for preparation thereof and composition containing the same
US4689414A (en) * 1986-02-24 1987-08-25 E. R. Squibb & Sons, Inc. 2-(substituted imino)-6-aryl-3,6-dihydro-4-substituted-1,5(2H)-pyrimidinecarboxylic acids and analogs
EP0367895A1 (en) 1988-10-06 1990-05-16 Sandoz Ag Pyrimidinyl-substituted hydroxyacids, lactones and esters and pharmaceutical compositions containing them
FR2665159B1 (fr) 1990-07-24 1992-11-13 Rhone Poulenc Sante Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
JP2648897B2 (ja) 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
WO1993008823A1 (en) 1991-11-06 1993-05-13 Tanabe Seiyaku Co., Ltd. Guanidinyl and related cell adhesion modulation compounds
JP3197971B2 (ja) 1993-03-01 2001-08-13 塩野義製薬株式会社 5−カルボアルコキシピリミジン誘導体の合成方法
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
NZ264063A (en) 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
PL320263A1 (en) 1994-11-16 1997-09-15 Synaptic Pharma Corp Dihydropyrimidines and their application
DE19517186A1 (de) 1995-05-11 1996-11-14 Bayer Ag Verfahren zur Herstellung substituierter 2-Fluor-pyrimidine
US6278001B1 (en) 1995-11-28 2001-08-21 L'oréal Method for preparing (+) compactin and (+) mevinolin analog compounds having a β-hydroxy-δ-lactone grouping
FR2741620B1 (fr) 1995-11-28 1997-12-26 Oreal Procede de preparation de composes a groupement beta-hydroxy -delta-lactone analogues de la (+) compactine et de la (+) mevinoline
KR19990072125A (ko) 1995-12-14 1999-09-27 폴락 돈나 엘. 디하이드로피리미디논의 제조 방법
US5958934A (en) 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
SE9702563D0 (sv) 1997-07-02 1997-07-02 Astra Ab Compounds
AU8680598A (en) 1997-08-05 1999-03-01 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonist
GB9903472D0 (en) 1999-02-17 1999-04-07 Zeneca Ltd Chemical process
EP1193259A4 (en) * 1999-06-23 2003-01-29 Ajinomoto Kk dihydropyrimidine
DE60023296T2 (de) 1999-07-13 2006-07-20 Lonza Ag Verfahren zur herstellung von 2-amino-4(4-fluorphenyl)-6-alkylpyrimidin-5-carbonsäureester
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
AU2000254249A1 (en) 2000-03-28 2001-10-08 Biocon India Limited Synthesis of (r-(r*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-
GB0011120D0 (en) 2000-05-09 2000-06-28 Avecia Ltd Process
GB0011163D0 (en) 2000-05-10 2000-06-28 Astrazeneca Ab Chemical compound
NL1015744C2 (nl) 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
AU2002318041B2 (en) 2001-07-13 2008-01-03 Astrazeneca Uk Limited Preparation of aminopyrimidine compounds
EP1323717A1 (en) 2001-12-27 2003-07-02 Dsm N.V. Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
KR100511533B1 (ko) 2002-04-09 2005-08-31 임광민 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법
EP1375493A1 (en) 2002-06-17 2004-01-02 Dsm N.V. Process for the preparation of an dioxane acetic acid ester
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
EP1578731B1 (en) 2002-12-16 2009-11-11 AstraZeneca UK Limited Process for the preparation of pyrimidine compounds
WO2004103977A2 (en) 2003-05-21 2004-12-02 Ciba Specialty Chemicals Holding Inc. Process for the preparation of pyrimidine derivatives
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
UY28501A1 (es) 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0321827D0 (en) 2003-09-18 2003-10-15 Astrazeneca Uk Ltd Chemical compounds
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
KR20090010126A (ko) 2003-12-24 2009-01-28 테바 파마슈티컬 인더스트리즈 리미티드 높은 syn형 대 anti형 비율을 지닌 스타틴의 제조 방법
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process

Also Published As

Publication number Publication date
BR0317313A (pt) 2005-11-08
EP2088142A3 (en) 2010-04-21
AR042355A1 (es) 2005-06-15
NO20110366L (no) 2005-07-07
CA2509344C (en) 2011-10-04
KR20050085674A (ko) 2005-08-29
EP2088142A2 (en) 2009-08-12
EP1578731A2 (en) 2005-09-28
AU2003288443B2 (en) 2007-10-25
US7524955B2 (en) 2009-04-28
ES2335279T3 (es) 2010-03-24
KR101060215B1 (ko) 2011-08-29
JP4579821B2 (ja) 2010-11-10
MY138051A (en) 2009-04-30
AU2003288443A1 (en) 2004-07-09
IL168884A (en) 2011-01-31
HK1080477A1 (en) 2006-04-28
WO2004054986A2 (en) 2004-07-01
WO2004054986A8 (en) 2005-07-21
NO330983B1 (no) 2011-08-29
CA2509344A1 (en) 2004-07-01
ATE448209T1 (de) 2009-11-15
DE60330050D1 (de) 2009-12-24
PT1578731E (pt) 2010-01-12
TWI322145B (en) 2010-03-21
NZ540722A (en) 2008-03-28
US20090264654A1 (en) 2009-10-22
WO2004054986A3 (en) 2004-12-02
JP2006515600A (ja) 2006-06-01
DK1578731T3 (da) 2010-02-15
EP1578731B1 (en) 2009-11-11
JP5318037B2 (ja) 2013-10-16
TW200418809A (en) 2004-10-01
US8273878B2 (en) 2012-09-25
JP2010248222A (ja) 2010-11-04
SI1578731T1 (sl) 2010-02-26
MXPA05006425A (es) 2005-08-19
US20060052604A1 (en) 2006-03-09
NO20052781L (no) 2005-07-07

Similar Documents

Publication Publication Date Title
CY1110605T1 (el) Διαδικασια για την παρασκευη ενωσεων πυριμιδινης
TR200402300T4 (tr) İmidazopirimidin türevleri ve triazolopirimidin türevleri.
CY1116298T1 (el) Ενωσεις 3,4-διυποκατεστημενου 1η-πυραζολιου και χρηση αυτων ως ρυθμιστες κινασων που εξαρτωνται απο κυκλινη (cdk) και κινασης-3 συνθασης γλυκογονου (gsk-3)
CY1108313T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
CY1115302T1 (el) Ενωση οξαζολιου και φαρμακευτικη συνθεση
CY1107532T1 (el) Παραγωγα ναφθυριδινης, παρασκευη και χρηση τους ως αναστολεις του ισοενζυμου 4 της φωσφοδιεστepασης (pde4)
EA200400893A1 (ru) N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств
CY1109882T1 (el) Νεα αλατα ατορβαστατινης και φαρμακευτικες συνθεσεις που τα περιεχουν
DK1117297T3 (da) Syntetiske analoger af ecteinascidin-743
CY1108019T1 (el) Ενωσεις πυριμιδινης
CY1109345T1 (el) ΠΑΡΑΓΩΓΑ ΥΠΟΚΑΤΕΣΤΗΜΕΝΗΣ 8-ΥΠΕΡΦΘΟΡΟΑΛΚΥΛΟ-6,7,8,9-ΤΕΤΡΑΫΔΡΟΠΥΡΙΜΙΔΟ (1,2-a) ΠΥΡΙΜΙΔΙΝ-4-ΟΝΗΣ
CY1108652T1 (el) Παραγωγα μορφολινυλ-ουριας για χρηση στη θεραπεια φλεγμονωδων ασθενειων
CY1107830T1 (el) Αντικαρκινικα αναλογα
CY1116540T1 (el) Μεθοδος παραγωγης 2'-δεοξυ-5-αζακυτιδινης (δεσιταβινη)
CY1109283T1 (el) Παραγωγα βαριολινης ως αντικαρκινικα μεσα
IT1315267B1 (it) Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
HUP0201475A2 (hu) Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
DE60016936D1 (de) Verflüssigungsmittel
CY1107805T1 (el) Στερεοεκλεκτικη μεθοδος παρασκευης νουκλεοζιτικων παραγωγων
ES2109236T3 (es) Reactivos tioacilantes y compuestos intermedios, tiopeptidos, y metodos para prepararlos y utilizarlos.
HUP0001245A1 (hu) Új eritromicinszármazékok, eljárás a vegyületek előállítására és gyógyszerként történő alkalmazásuk
CY1110038T1 (el) 4-(διαρυλομεθυλ)-1- πιπεραζινυλ παραγωγα
CY1105422T1 (el) Νεα πιπepιδινυλο-αλκυλαμινο-πυριδαζινονικα παραγωγα, μια διαδικασια για την παρασκευη τους και φαρμακευτικες συνθεσεις οι οποιες πepιεχουν τις εν λογω ενωσεις
DE60237652D1 (de) Variolinderivate und ihre Verwendung als Cytostatika
ES557208A0 (es) Un procedimiento para preparar derivados de dihidropirrol (112-b)-isoquinoleina